Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2007
12/26/2007EP1868605A2 Phenyl and pyridyl lta4h modulators
12/26/2007EP1751138B1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
12/26/2007EP1597248B1 Sulfonamide derivatives as ppar modulators
12/26/2007EP1539708B1 Benzimidazolones and their use as cytokine inhibitors
12/26/2007EP1233769B1 Imidazole derivatives
12/26/2007CN101094848A Organic compounds
12/26/2007CN101094846A 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists
12/26/2007CN101094845A Substituted thiophenes
12/26/2007CN101094837A Novel beta agonists, method for producing the same and their use as drugs
12/26/2007CN100357295C Macrocyclic pyrimidines, their production and use as pharmaceutical agents
12/26/2007CN100357290C Pesticidal 3-(substituted phenyl)-5-(thienyl or furyl)-1,2,4-triazoles
12/26/2007CN100357278C Substituted triazole diamine derivatives as kinase inhibitors
12/26/2007CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
12/26/2007CN100357273C Process for the production of substituted nicotinic acid esters
12/26/2007CN100357270C D-proline derivative
12/26/2007CN100356979C Integrin expression inhibitors
12/25/2007US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
12/25/2007US7312336 Ligands for the delta opiod receptor; novel compounds which possess a piperidine ring with an exocyclic double bond do not show significant convulsive effects when administered systemically
12/25/2007US7312245 controlling harmful drug resistant fungi at lower concentrations; safe for crops; rice blast
12/25/2007US7312230 Carboxylic acid derivatives as IP antagonists
12/25/2007US7312227 Autoimmune diseases; Alzheimer's disease; Parkinson's disease; bone disorders; liver disorders; rheumatic disease; amythrophiic lateral sclerosis
12/25/2007US7312225 inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases
12/25/2007US7312222 Heterocyclic piperidines as modulators of chemokine receptor activity
12/25/2007US7312221 Therapeutic treatment of endotoxic shock with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating psoriasis, arthritis, osteoarthritis, glomerulonephriti, autoimmune disorder include diabetes, asthma, or multiple sclerosis
12/25/2007US7312220 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/25/2007US7312218 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide
12/25/2007US7312214 Anticoagulants; atherosclerosis; strokes; thrombosis; cardiovascular disorders
12/25/2007US7312200 9-ketospinosyn derivatives
12/25/2007US7312180 Substituted 4-(4-trifluoromethylpyrazolyl)pyrimidines
12/25/2007US7312179 Cyclopropyl-thienyl-carboxamide as fungicides
12/21/2007WO2007146225A2 Heterocyclic aspartyl protease inhibitors
12/21/2007WO2007144637A1 2 -oxyheteroarylamide derivatives as parp inhibitors
12/21/2007WO2007122634A3 Pyrimidinediones as tyrosine kinase inhibitors
12/21/2007WO2007117607A3 Quinazolines for pdk1 inhibition
12/21/2007WO2007063418A3 Substituted indole compounds having nos inhibitory activity
12/21/2007WO2007062078A3 Thrombopoietin activity modulating compounds and methods
12/21/2007WO2007001225A8 Thiophene-2-carboxamide derivatives as alpha 7 nicotinic receptor modulators.
12/21/2007CA2654927A1 Substituted phenyl acetic acids as dp-2 antagonists
12/21/2007CA2654515A1 Substituted 3-cyanopyridines as protein kinase inhibitors
12/21/2007CA2653650A1 Heterocyclic aspartyl protease inhibitors
12/21/2007CA2650666A1 Substituted cyanopyridines as protein kinase inhibitors
12/20/2007US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
12/20/2007US20070293524 Salts, hydrates, solvatesand/or N-oxides; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors; inhibiting an Fc receptor signal transduction cascade
12/20/2007US20070293523 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293522 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293520 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/20/2007US20070293484 Thiophene Heteroaryl Amines
12/20/2007US20070293455 Silylated Carboxamides
12/20/2007US20070293423 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
12/20/2007US20070292718 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
12/20/2007US20070290198 organic field-effect transistors; high mobility and high on/off ratio; 5,5'-di(4-octyloxy-phenyl)-2,2'-bithiophene
12/20/2007US20070289625 -Conjugated Mono-, Oligo-and Polymeric Compounds, and Photovoltaic Cells Comprising Them
12/19/2007EP1867651A1 Semi-conducting coatings containing organic linear thiophen-phenyl oligomers
12/19/2007EP1867645A1 Variolin derivatives and their use as antitumor agents
12/19/2007EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents
12/19/2007EP1866304A2 Substituted oxindole derivatives, medicaments containing the latter and use thereof
12/19/2007EP1866287A2 Substituted pyrazolyl oxyphenyl derivatives used as herbicides
12/19/2007EP1664031B1 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors
12/19/2007EP1453806B1 Aminotetralin derivatives as muscarinic receptor antagonist
12/19/2007EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007EP1165068B1 C10 heterosubstituted acetate taxanes as antitumor agents
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007CN101090898A 5-HT7 receptor antagonists
12/19/2007CN101088997A Improved process of preparing Raltitrexed
12/19/2007CN100355856C 可溶液加工的磷光材料 Solution processable phosphorescent materials
12/19/2007CN100355751C 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders
12/19/2007CN100355748C Aromatic hydrazide kind compound and its use in preparation of immune inhibitor
12/19/2007CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
12/19/2007CN100355728C Inhibitors of dipeptidyl peptidase IV
12/18/2007US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
12/18/2007US7309716 Inhibitors of voltage-gated sodium channels; acute, chronic, neuropathic, or inflammatory pain such as femur cancer pain; non-malignant chronic bone pain; rheumatoid arthritis; osteoarthritis; spinal stenosis; neuropathic low back pain; neuropathic low back pain; myofascial pain syndrome; fibromyalgia
12/18/2007US7309708 Serine protease inhibition via N-(distubstituted aminomethylcarbonyl)-2-[N-(1-sulfonylamido-1-cyclopropanyl)amido]pyrrolidines
12/18/2007US7309704 Piperidinyl- and pyrimidinyl-ureas: N-(1-acetyl-4-piperidinyl)-N-methyl-N'-(5-(3,5-difluorophenyl)-2-pyrimidinyl)urea; metabolic disorders, eating disorders, disorders associated with obesity: type II diabetes, insulin resistance, hyperlipidemia or hypertension.
12/18/2007US7309701 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example
12/18/2007CA2217074C Process for detecting target nucleic acid, process for quantifying the same, and pyrylium compound for chemiluminescence analysis
12/13/2007WO2007143456A2 Benzimidazol substituted thiophene derivatives with activity on plk
12/13/2007WO2007142583A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia.
12/13/2007WO2007141504A1 Fused thiophene derivatives as kinase inhibitors
12/13/2007WO2007140847A1 Materials for organic electroluminescent devices
12/13/2007WO2007109251A3 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
12/13/2007WO2007109211A3 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses
12/13/2007WO2007105154A3 Antibiotic compounds
12/13/2007WO2007078813A3 2-AMINO-5-PIPERIDINYLIMIDAZOLONE COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION
12/13/2007US20070287843 Methods and Intermediates for the Synthesis of Delta-9 Tetrahydrocannabinol
12/13/2007US20070287842 Conjugated Thiophenes Having Conducting Properties and Synthesis of Same
12/13/2007US20070287708 Substituted 3-cyanopyridines as protein kinase inhibitors
12/13/2007US20070286997 Material Composition for Conductive Layers in Electronic Devices
12/13/2007CA2654138A1 Novel compounds
12/13/2007CA2653655A1 Organic compounds
12/12/2007EP1864981A1 Thrombopoietin mimetics
12/12/2007EP1864980A1 Antifungal agent containing pyridine derivative
12/12/2007EP1864979A1 Imidazole-derivatives as TAFAIa-inhibitors
12/12/2007EP1864976A1 Propane-1,3-dion derivative or salt thereof
12/12/2007EP1864975A2 Novel compounds
12/12/2007EP1863798A1 Indole derivatives
12/12/2007EP1863787A1 Hydogrenated benzo[c]thiophene derivatives as immunomodulators
12/12/2007EP1863785A1 Novel thiophene sulfoximines for treating cmplement-mediated deseases and conditions
1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 523